DRMAW Dermata Therapeutics, Inc. - Warrant

$0.02
Price · May 19, 2026
Fundamentals as of May 13, 2026

DRMAW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.02
Market Cap
P/E (TTM)
EPS (TTM)
$-8.16
Revenue (TTM)
Div Yield
ROE
-127.7%
Debt/Equity
52W Range
$0 – $0

DRMAW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-8.16
3-point trend, +79.6%
2023-12-31 2025-12-31
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
DRMAW
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
DRMAW
Peer Median
ROA
4-point trend, -2.6%
-132.6%
ROE
4-point trend, -82.6%
-127.7%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
DRMAW
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
DRMAW
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
DRMAW
Peer Median
EPS (Diluted)
3-point trend, +79.6%
$-8.16

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
DRMAW
Peer Median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for DRMAW
Metric Trend 202520242023202220212020
R&D Expense 6-point trend, +82.2% $3M $8M $4M $6M $3M $2M
SG&A Expense 6-point trend, +209.5% $5M $4M $4M $4M $4M $2M
Operating Expenses 4-point trend, -19.6% $8M $13M $8M $10M · ·
Operating Income 6-point trend, -145.0% $-8M $-13M $-8M $-10M $-8M $-3M
Interest Expense 2-point trend, -76.9% · · · · $45.6K $197.3K
Interest Income 2-point trend, -4.8% $215.0K $225.8K · · · ·
Income Tax Flat — no change across 4 periods · · $0 $0 $0 $0
Net Income 6-point trend, -133.5% $-8M $-12M $-8M $-10M $-8M $-3M
EPS (Basic) 6-point trend, -382.8% $-8.16 $-80.32 $-39.99 $-13.92 $-2.43 $-1.69
EPS (Diluted) 3-point trend, +79.6% $-8.16 $-80.32 $-39.99 · · ·
Shares (Basic) 4-point trend, -51.5% 926,192 152,974 · · 4,302,232 1,911,009
Shares (Diluted) 3-point trend, +375.1% 926,192 152,974 194,928 · · ·
EBITDA 4-point trend, +1.1% $-8M $-13M $-8M · $-8M ·
Balance Sheet 15
Annual Balance Sheet data for DRMAW
Metric Trend 202520242023202220212020
Cash & Equivalents 5-point trend, +1318.2% $8M $3M · $6M $11M $530.4K
Prepaid Expense 6-point trend, +355.5% $341.8K $372.3K $540.5K $703.2K $825.1K $75.1K
Current Assets 2-point trend, +1819.9% · · · · $12M $605.5K
PP&E (Net) Flat — no change across 2 periods · · · · $0 $0
Total Assets 6-point trend, +1198.8% $8M $4M $8M $7M $12M $605.5K
Accounts Payable 6-point trend, +341.9% $460.8K $808.0K $866.0K $496.7K $515.2K $104.3K
Current Liabilities 2-point trend, -59.9% · · · · $2M $4M
Total Liabilities 6-point trend, -56.6% $2M $2M $2M $922.6K $2M $4M
Total Debt · · · · $0 ·
Common Stock 6-point trend, +266.00 $266 $25 $26 $77 $833 $0
Paid-in Capital 6-point trend, +79457010.00 $79M $67M $60M $52M $46M $0
Retained Earnings 6-point trend, -160.8% $-73M $-66M $-53M $-46M $-36M $-28M
Stockholders' Equity 6-point trend, +295.8% $6M $2M $6M $6M $10M $-3M
Liabilities + Equity 6-point trend, +1198.8% $8M $4M $8M $7M $12M $605.5K
Shares Outstanding 5-point trend, -68.1% 2,660,110 251,725 261,998 770,115 8,328,629 ·
Cash Flow 7
Annual Cash Flow data for DRMAW
Metric Trend 202520242023202220212020
D&A 2-point trend, -100.0% · · · · $0 $322
Stock-based Comp 6-point trend, +143732.00 $143.7K $657.6K $522.1K $930.3K $2M $0
Operating Cash Flow 6-point trend, -93.6% $-8M $-11M $-6M $-9M $-6M $-4M
Stock Issued 5-point trend, -20.9% $12M $7M $8M $4M $15M ·
Net Stock Activity 3-point trend, +60.0% $12M $7M $8M · · ·
Financing Cash Flow 6-point trend, +372.0% $12M $7M $8M $4M $16M $3M
Net Change in Cash 4-point trend, +398.4% $4M $-4M · · $10M $-1M
Profitability 2
Annual Profitability data for DRMAW
Metric Trend 202520242023202220212020
ROA 4-point trend, -2.6% -132.6% -213.5% -104.5% · -129.2% ·
ROE 4-point trend, -82.6% -127.7% -389.9% -122.2% · -69.9% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for DRMAW
Metric Trend 202520242023202220212020
Current Ratio · · · · 7.7 ·
Quick Ratio · · · · 7.1 ·
Debt / Equity · · · · 0.0 ·
Interest Coverage · · · · -172.3 ·
Per Share 4
Annual Per Share data for DRMAW
Metric Trend 202520242023202220212020
Book Value / Share 4-point trend, +92.8% $2.34 $0.62 $1.62 · $1.21 ·
Cash Flow / Share 2-point trend, -14.8% $-8.38 $-7.30 · · · ·
Cash / Share 2-point trend, +118.1% $2.83 · · · $1.30 ·
EPS (TTM) 3-point trend, +79.6% $-8.16 $-80.32 $-39.99 · · ·
Valuation (TTM) 2
Annual Valuation (TTM) data for DRMAW
Metric Trend 202520242023202220212020
Revenue TTM 5-point trend, +500.9% $182.8K $182.8K $182.8K $63.6K $-45.6K ·
Net Income TTM 5-point trend, +4.4% $-8M $-12M $-8M $-10M $-8M ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-8M$-12M$-8M$-10M$-8M
Diluted EPS $-8.16$-80.32$-39.99
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.0
Current Ratio 7.7
Quick Ratio 7.1

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.